| || |
GAVI and The Vaccine Fund - Overview
Global Alliance for Vaccines and Immunization is an historic alliance between
the private and public sector committed to one goal: saving children’s lives
and people’s health through the widespread use of vaccines.
emerged in 1999 in response to stagnating immunization rates and widening global
disparities in access to vaccines. International organizations, governments, the
vaccine industry, research institutions, and major philanthropists collectively
serve the shared GAVI objectives: expanding the reach of immunization services,
introducing priority new vaccines, and establishing tools and systems to promote
sustainable financing in developing countries.
Vaccine Fund has been created to support the GAVI objectives. It provides financing
to the world’s poorest countries to strengthen health infrastructures and introduce
new and under-used vaccines. Grants are made based on a rigorous application process
in which country proposals are reviewed by a panel of experts, most of whom are
themselves national health ministry staff.
unique structure allows the alliance to capitalize on existing systems and diverse
technical and on-the-ground expertise.
high-level GAVI Board maintains a visionary outlook in setting policies.
Working Group ensures that Board decisions are acted upon in the partner organizations,
and a small secretariat coordinates between partners and manages the review of
country proposals to The Vaccine Fund.
task forces (advocacy, financing, implementation, and research and development)
draw upon a wider network of expertise to guide action.
working groups provide technical support to countries.
crucially, national inter-agency coordinating committees (ICCs) provide a forum
for joint strategy development and monitoring at the country level.
the past two years, the partners in the Alliance have:
more than US$ 900 million from The Vaccine Fund to 60 developing country government
health programs, over five years.
more than 30 million vaccine doses to 27 countries, and transferred funds to national
immunization programs in 34 countries.
a viable market in poor countries for new combination vaccines, a demand that
vaccine manufacturers are gearing up to satisfy.
a new protocol to assess the quality of immunization coverage data, the immunization
Data Quality Audit, or DQA.
to prioritize three new vaccines in late stages of development, against viral
diarrhoea, pneumonia, and meningitis diseases.
The Vaccine Fund truly international: Norway, the United Kingdom, the United States,
The Netherlands, Sweden, Denmark, Canada and private donors have all joined the
Bill & Melinda Gates Foundation to support The Vaccine Fund, pushing its total
commitments to $1.2 billion.
the partnership evolves, it will continue to seek catalytic and sustainable approaches
to funding. In the future, GAVI and The Vaccine Fund may channel resources toward
increased support to health infrastructure, other under-used vaccines, or new
approaches to reaching every child with essential health care.